The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia
Condition(s):Schizophrenia; Myelin Degeneration; Cognition DisorderLast Updated:April 22, 2022Unknown status
Hide Studies Not Open or Pending
Condition(s):Schizophrenia; Myelin Degeneration; Cognition DisorderLast Updated:April 22, 2022Unknown status
Condition(s):Cervical Spondylosis With Myelopathy; Degenerative Cervical MyelopathyLast Updated:May 27, 2022Recruiting
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:October 26, 2023Recruiting
Condition(s):Multiple SclerosisLast Updated:September 28, 2022Not yet recruiting
Condition(s):Multiple SclerosisLast Updated:August 31, 2020Unknown status
Condition(s):Multiple Sclerosis; Optic NeuritisLast Updated:August 28, 2019Unknown status
Condition(s):Cerebrovascular AccidentLast Updated:July 21, 2017Completed
Condition(s):Multiple SclerosisLast Updated:December 3, 2018Terminated
Condition(s):Multiple SclerosisLast Updated:October 8, 2020Completed
Condition(s):Multiple SclerosisLast Updated:October 23, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.